Elmind Capital

Elmind Capital as of June 30, 2026

Portfolio Holdings for Elmind Capital

Elmind Capital holds 35 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Cogent Biosciences (COGT) 11.4 $45M 1.2M 38.70
Syndax Pharmaceuticals (SNDX) 10.2 $41M 1.9M 21.86
Celldex Therapeutics Com New (CLDX) 9.3 $37M 990k 37.21
Relay Therapeutics (RLAY) 6.9 $27M 1.5M 18.71
Vaxcyte (PCVX) 6.6 $26M 452k 58.13
Vera Therapeutics Cl A (VERA) 4.7 $19M 437k 42.91
Pharvaris N V (PHVS) 4.6 $18M 526k 34.58
Miragen Therapeutics (VRDN) 4.5 $18M 985k 18.37
Cytomx Therapeutics (CTMX) 4.3 $17M 4.6M 3.75
Travere Therapeutics (TVTX) 4.2 $17M 293k 56.81
Legend Biotech Corp Sponsored Ads (LEGN) 4.1 $17M 571k 28.88
Beam Therapeutics (BEAM) 4.1 $16M 476k 34.32
Cullinan Oncology (CGEM) 3.2 $13M 690k 18.21
Nurix Therapeutics (NRIX) 2.8 $11M 460k 24.26
Krystal Biotech (KRYS) 2.1 $8.2M 22k 371.67
United Therapeutics Corporation (UTHR) 2.0 $8.1M 15k 541.83
Summit Therapeutics (SMMT) 1.8 $7.2M 494k 14.57
Insmed Com Par $.01 (INSM) 1.7 $6.9M 65k 106.62
BioCryst Pharmaceuticals (BCRX) 1.3 $5.2M 520k 10.00
Mbx Biosciences (MBX) 1.3 $5.0M 91k 55.20
Protagonist Therapeutics (PTGX) 1.2 $4.7M 38k 122.58
Urogen Pharma (URGN) 1.1 $4.4M 120k 36.80
Dbv Technologies S A Sponsored Ads (DBVT) 1.1 $4.3M 265k 16.40
Alumis (ALMS) 0.9 $3.7M 130k 28.14
Supernus Pharmaceuticals (SUPN) 0.8 $3.3M 70k 46.51
BioMarin Pharmaceutical (BMRN) 0.7 $2.7M 47k 57.22
Immunocore Hldgs Ads (IMCR) 0.6 $2.6M 81k 31.75
Amylyx Pharmaceuticals (AMLX) 0.5 $2.0M 112k 17.96
Alector (ALEC) 0.5 $1.8M 900k 2.01
Septerna (SEPN) 0.4 $1.7M 49k 33.49
Design Therapeutics (DSGN) 0.4 $1.6M 108k 14.47
Sutro Biopharma Com Shs (STRO) 0.3 $1.1M 32k 33.20
Wave Life Sciences SHS (WVE) 0.3 $1.0M 178k 5.81
Tyra Biosciences (TYRA) 0.2 $639k 20k 31.94
Engene Therapeutics (ENGN) 0.1 $363k 210k 1.73